CA Patent

CA2797560A1 — Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males

Assigned to Salix Pharmaceuticals Inc · Expires 2011-11-03 · 15y expired

What this patent protects

The instant application provides methods and compositions for the treatment of male subjects having ulcerative colitis.

USPTO Abstract

The instant application provides methods and compositions for the treatment of male subjects having ulcerative colitis.

Drugs covered by this patent

Patent Metadata

Patent number
CA2797560A1
Jurisdiction
CA
Classification
—
Expires
2011-11-03
Drug substance claim
No
Drug product claim
No
Assignee
Salix Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.